Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Julphar
Dow
Baxter
Fish and Richardson
Boehringer Ingelheim
Federal Trade Commission
Cantor Fitzgerald

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,727,228

« Back to Dashboard

Title: Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
Abstract:The present invention relates to compositions and methods for administering compositions in solutions for killing adult lice and the ova comprising water, PVM/MA Decadiene crosspolymers, propylene glycol, a mixture of cetyl and stearyl alcohols, Ceteareth-20; stearalkonium chloride; benzyl alcohol; hexylene glycol; pentylene glycol, isopropyl alcohol; a mixture of spinosyn A and spinosyn D in a weight ratio of 80:20, BHT; and sodium hydroxide.
Inventor(s): Janssen; Herwig (Princeton, NJ), Ho; Kie (Princeton, NJ), Nystrand; Glenn (Lebanon, NJ), Williams; Dexter (Dayton, NJ), Lamb; C. Scott (Doylestown, PA)
Assignee: Johnson & Johnson Consumer Companies, Inc. (Skillman, NJ)
Filing Date:Apr 25, 2001
Application Number:09/841,715
Claims:1. A composition comprising: About 44% water; About 1.1% polyvinyl methyl ether/maleic anhydride Decadiene, crosspolymers; About 3% propylene glycol; About 3% cetearyl alcohol; About 0.9% polyethylene glycol ether of cetearyl alcohol; About 4.17% stearalkonium chloride; About 10% benzyl alcohol; About 6% hexylene glycol; About 4% pentylene glycol; About 20% isopropyl alcohol; About 2.19% mixture of spinosyn A & D in an approximate 85:15 weight ratio; About 0.1% butylated hydroxytoluene; and About 1.29% sodium hydroxide (10% solution).

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
QuintilesIMS
Harvard Business School
Healthtrust
Federal Trade Commission
Julphar
Argus Health
Cipla
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.